US FDA Mandates New Safety Warnings for GLP-1 Drugs Due to Vision Loss Risk
Washington:The United States has issued new safety warnings for GLP-1 medicines, highlighting a potential increased risk of a rare eye condition that could lead to permanent vision loss. The Food and Drug Administration (FDA) announced on Monday that …